National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -6 of 6         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


Pharmaceutical / Industry


D4320C00015
NCT00626548


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Other


2006-01
NCT00420563

Last Modified: 1/14/2009     First Published: 7/13/2007  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


GOG-0224
GOG-0224, NCT00503581


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Other


06-685
Version April 9, 2007, NCT00483327

Last Modified: 1/14/2009     First Published: 8/5/2008  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


Not specified


NCI


GOG-0248
GOG-0248, NCT00729586


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Supportive care


Active


Under 18


Other


H06-03499
CW06- 0294, NCT00439101

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov